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During ontogeny, fetal liver (FL) acts as a major site for hematopoietic stem cell (HSC) 
maturation and expansion, while HSCs in the adult bone marrow (ABM) are largely 
quiescent. HSCs in the FL possess faster repopulation capacity as compared with ABM HSCs. 
However, the molecular mechanism regulating the greater self-renewal potential of FL HSCs 
has not yet extensively been assessed. Recently, we published  RNA-sequencing based gene 
expression analysis on FL HSCs from 14.5 day mouse embryo (E14.5) in comparison to the 
ABM HSCs. We reanalyzed this data to identify key transcriptional regulators that play 
important roles in the expansion of HSCs during development. The comparison of FL E14.5 
with ABM HSCs identified more than 1400 differentially expressed genes. More than 200 
genes were shortlisted based on the GO annotation term “transcription”. By morpholino 
based knockdown studies in zebrafish, we assessed the function of 18 of these regulators, 
previously not associated with HSC proliferation. Our studies identified a previously 
unknown role for tdg, uhrf1, uchl5, and ncoa1 in the emergence of definitive hematopoiesis 
in zebrafish. In conclusion, we demonstrate that identification of genes involved in 
transcriptional regulation differentially expressed between expanding FL HSCs and 












































































































































































































































































































































































































































Long-term repopulating (LT) hematopoietic stem cells (HSCs) give rise to all the blood cell 
lineages throughout the lifespan of adult mammals [1]. One of the hallmark features of LT-
HSCs is their ability to self-renew, which is governed by cell-intrinsic and -extrinsic factors. 
Due to different requirements of HSCs at different stages of development, the molecular 
determinants that regulate self-renewal are believed to be stage specific. During 
development, particularly in the fetal liver (FL), the main role of HSCs is to rapidly produce 
sufficient numbers of stem cells for the adult life while also giving rise to homeostatic levels 
of differentiated blood progeny. That the fetal liver is a pivotal organ where definitive HSCs 
expand [2], is reflected in the percentage of FL HSCs (30-35%) that are actively cycling. The 
increased proliferative potential of FL HSCs is evident from the studies wherein FL and ABM 
HSCs were grafted into irradiated hosts; resulting in a significantly faster HSC expansion 
from FL compared with ABM grafts [3]. By contrast, from 4 weeks after birth onwards more 
than 95% of the HSCs in adult bone marrow (ABM) are quiescent. Rare asymmetrical 
divisions allow the continuous supply of mature blood cells without losing primitive HSCs 
throughout the lifetime of an individual [4]. Differences in the cell surface antigen 
expression as well as global gene expression profiles have been described between FL HSCs 
and ABM HSCs [5-8]. 
Although it is well accepted that significant differences exist between the ability of FL and 
ABM HSCs to undergo symmetrical, self-renewing cell divisions without stem cell 
exhaustion, only few studies have addressed molecular pathways underlying these 
differences. For instance, the higher expansion potential of FL derived HSCs has been at 
least in part ascribed to Lin28b-let-7-Hmga2 mediated signaling, even if Lin28b cannot 
reactivate the FL HSC-like self-renewal properties in ABM HSCs [9]. By contrast, Sox17, 
which is required for the maintenance of FL HSC function, can also re-introduce the FL 
proliferative phenotype in ABM HSCs [10,11]. Interestingly, conditional deletion of Lis1 in FL 
hematopoietic cells using Vav-cre was shown to cause defects HSC expansion and 
embryonic lethality; and a similar phenotype was observed after the deletion of Lis1 in adult 































































































































































































































































































































































































































 HSC which caused decreased HSC self-renewal and differentiation in competitive 
repopulation assays [12,13].  
Gaining further insights into the molecular regulators that support symmetrical self-renewal 
is of significant clinical relevance; in the setting of bone marrow failure syndromes, ex vivo 
HSC expansion methods and in the field of leukemogenesis. To uncover candidate molecular 
regulators for FL HSC self-renewal, we performed RNA-sequencing analysis to define the 
differences in the genome-wide transcriptome of HSCs from FL and ABM.  
To investigate the functional role of differentially expressed genes for their importance in 
definitive hematopoiesis, we used zebrafish, Danio Rerio, as the model organism. In 
Zebrafish, definitive HSCs that support multi-lineage engraftment appear along the ventral 
wall of dorsal aorta, which is an equivalent of the AGM region and express c-myb and runx1 
[14,15]. Several signaling pathways have been identified that regulate specification and 
development of HSCs in zebrafish, including Notch, Runx1, fibroblast growth factor, vascular 
endothelial growth factor, bone morphogenetic protein and Hedgehog [16-19]. These 
cellular and molecular mechanisms underlying the emergence or specification of these 
multipotent hematopoietic stem and progenitors cells (HSPCs) are largely conserved 
between mammals and zebrafish [16,20-22]. Hence, the easy accessibility to manipulate 
and visualize early stage embryos and the relatively high homology in the genetic regulation 
of hematopoiesis makes genetic screens in zebrafish a very useful method to interrogate in 
a semi high throughput manner the role of specific genes in hematopoiesis.  
We used our earlier published RNASeq [23] data to identify 18 differentially expressed 
genes between E14.5 FL and ABM HSC that could be important regulators for HSC 
expansion. Morpholino anti-sense oligonucleotide (MO) knockdown technology was used to 
address their possible role in hematopoiesis. Our study identified 4 differentially expressed 
genes, with previously unknown function in HSC biology, to affect emergence of definitive 
hematopoiesis in zebrafish larvae.  
  
































































































































































































































































































































































































































Animals: Six to ten weeks old C57BL/6J-CD45.2 (Centre d’Elevage R. Janvier, Le Genest-St 
Isle, France, http://www.criver.com/) were bred and maintained in the animal facility at KU 
Leuven, Belgium. During the experiments, mice were maintained in isolator cages, fed with 
autoclaved acidified water, and irradiated food ad libitum. All the experimental procedures 
involving mice and Zebrafish were approved by the Institutional Animal Ethics Committee of 
KU Leuven. 
Isolation of LT-HSC from bone marrow and fetal liver:  
The isolation and purification of LT-HSC from murine FL E14.5 and ABM has been described 
in our pervious study [23]. 
RNA-sequencing and bioinformatics analysis:  
RNA-seq data obtained from E14.5 FL and BM HSCs described in [23] were reanalyzed in a 
similar manner as previously described[23]. Unlike in our previous publication [23], the high 
quality reads were aligned to the mouse reference genome mm9 using SOAPaligner/SOAP2. 
Quality was checked for the alignment and later downstream analysis including gene 
annotation, gene expression, alternative splicing and novel transcript prediction was 
performed. The differential expression analysis of genes was performed using the R package 
DESeq[24] and differentially expressed genes were identified using the following thresholds: 
false discovery rate (FDR) ≤ 0.05 and log2 fold change ≥ 1.0. The gene-set enrichment test 
was then carried out to detect significantly enriched gene sets using Genecodis[25]. 
Sequencing data related to FL and BM HSC can be accessed via ArrayExpress database 
(http://www.ebi.ac.uk/arrayexpress) with accession number: E- MTAB-4034. 
Quantitative RT-PCR:  
For each replicate, we used three times 6 embryos that had been injected with MOs  as well 
as uninjected controls 48 hour post-fertilization. 4-6 replicates were collected and RNA was 
extracted using the GenElute Mammalian Total RNA Miniprep Kit (Sigma-Aldrich) following 































































































































































































































































































































































































































 manufacturer’s instructions. A DNase treatment was performed while the RNA was bound 
to the column using an On-Column DNaseI Digestion Set (Sigma-Aldrich). cDNA was 
synthetized using the SuperScript III First-Strand Synthesis SuperMix for qRT-PCR 
(Invitrogen) according to manufacture protocol. qRT-PCR was performed in a FrameStar 384 
plate (4titude) using the Platinum SYBR Green qRT-PCR SuperMix-UDG (Invitrogen). Rox 
Reference Dye was added to the Platinum SYBR Green qPCR SuperMix-UDG in a 
concentration of 50 nM. A list of primers used for the qRT-PCR can be found in Table S1. We 
measured the transcript levels for the erythroid-specific gene hbae1 and the myeloid-
specific gene lcp1. Gene expression for different transcripts was calculated relative to gapdh 
as a housekeeping gene. Fold change was calculated relative to uninjected controls. The 
qRT-PCR was performed using ViiA7 Real-Time PCR System (Applied Biosystems). 
For some genes, differentially expressed gene identified between ABM and E14.5 FL were 
analysed by qRT-PCR to confirm differential gene expression. RNA isolation and qRT-PCR 
was performed as previously described and list of primers used for the qRT-PCR can be 
found in Table S1. Gene expression for different transcripts was calculated relative to β-
actin as a housekeeping gene.  
Morpholino injection: 
Zebrafish (Danio rerio) were bred, raised, and maintained according to Animal handling 
guidelines at KU Leuven. Embryos were incubated at 28.5°C and staged according to hours 
post-fertilization (hpf) and morphological features as published (Kimmel et al. 1995). For 
high throughput screening, double transgenic zebrafish with a DsRed reporter under the 
control of the gata1 promoter (Tg(gata1:DsRed)) and EGFP reporter under the control of 
the flk1 promoter (Tg(flk1:EGFP)) were used. Morpholino antisense oligonucleotides (MOs), 
targeting the translational initiation (starting codon) of candidate genes (Table S2), 
preventing protein translation, were obtained from Gene tools, LLC (OR, USA). For some 
genes we designed second MOs targeting the splice junction (Table S2) 
MOs were injected at the 1-2 cell stage (70-100 embryos) with a starting concentration of 































































































































































































































































































































































































































 4ng/embryo. The concentration was increased to 5, 6, 7ng if there was no defect on blood 
flow (increase or decrease in DsRed (gata1) signal) and the concentration was decreased to 
3, 2, 1.5ng if there was a defect in blood to identify the lowest concentration possible. 
Embryos were screened under fluorescence microscope at 48hr post microinjection and 
imaged using Zeiss Axio Imager microscope. 
Whole-mount in situ hybridization (WISH): 
WISH for c-myb and runx1 expression was performed on uninjected and MO injected 
embryos at 36hpf as described previously[26]. In brief, in situ hybridization using DIG-
labeled antisense riboprobes runx1 and c-myb that were transcribed from linearized 
plasmid using T7 RNA polymerase (Roche). 36hpf embryos were fixed with 4% PFA 
overnight and permeabilized using ProteinaseK (1mg/ml) for 20 minute. Embryos were 
hybridized overnight in water bath at 68°C. After hybridization embryos were washed 
several times as previously described[26] and rinse in MABT (Maleic Acid buffer + 0.1% 
tween-20). Next, incubate embryos in blocking solution (1 part 10% Boehringer Mannheim 
Blocking reagent (BMB), 1 part lamb serum, 8 parts MAB) at RT for 2-3 hours.  Hybridization 
was detected using anti-DIG antibody (Roche) coupled to alkaline phosphatase (AP). 
Embryos were washed by MABT (6 x 15 minutes) to remove excess of antibody. DIG 
antibody-alkaline phosphatase conjugate was detected using NBT/BCIP (Sigma). Stained 
embryos were mounted in 70% glycerol and imaged on an Olympus compound microscope 
with a camera. 
Statistical analysis: The significance of difference was estimated by two-tailed Student’s t-





































































































































































































































































































































































































































Genome-wide transcriptome analysis of fetal liver and adult bone marrow LT-HSCs 
To define developmentally regulated differences in the transcriptome of extensively self-
renewing FL HSCs and quiescent ABM HSCs, we re-analyzed RNA-seq obtained from HSCs 
derived from mouse FL and ABM as previously described [23]. LT-HSCs were isolated from 
E14.5 FL as Lin-Sca-1+Mac-1+CD150+CD48- cells, and from ABM HSCs as Lin-Sca-1+c-kit+ 
CD150+CD48- cells using FACS. RNA from all samples was amplified and subjected to 91 bp 
pair-end sequencing at Beijing Genomics Institute (BGI, Shenzhen). Raw sequencing reads 
that had been filtered into clean reads, were aligned to the reference genome sequence 
mm9 using SOAPaligner/SOAP2. Alignment data were then used to calculate the distribution 
of reads on reference genes/genome (Fig. S1A,B), and to obtain normalized expression 
values by calculating RPKM (Reads Per Kilobase of transcript per Million mapped reads) 
(Table S3). Pearson correlation between the biological replicates demonstrated that 
samples at each stage were highly correlated (Fig. S1C). Principal component analysis (PCA) 
showed that the FL HSC populations were distinct from ABM HSCs (Fig. 1A).  
Next, we performed a pair-wise comparison between both FL E14.5 and adult BM HSCs to 
obtain differentially expressed genes (DEG) using the DESeq method (Fig. 1B and Table 
S4).[27] Because HSCs expand most abundantly at around E14.5, we compared the 
transcriptome of E14.5 FL HSCs with the transcriptome of ABM HSCs obtained from 8-week 
old mice, at which time HSCs are quiescent. We identified 1442 genes differentially 
expressed between E14.5 FL HSCs and the ABM derived HSCs (Log2FC ≥ 1 and FDR ≤  
0.05)(703 genes were more highly expressed and 739 genes less expressed in FL HSCs 
compared with ABM HSCs) (Fig. 1B and Table S4).  
We performed gene-set enrichment analysis for biological processes on genes differentially 
expressed between E14.5 FL and ABM (from our data published earlier [23]) using the web-
based application, GeneCodis3 [25]. As expected, genes more highly expressed in FL E14.5 
HSCs were enriched for biological processes related to cell proliferation, such as cell cycle, 































































































































































































































































































































































































































 cell division, mitosis, DNA replication and DNA repair (Fig. 1C). By contrast, genes more 
highly expressed in quiescent BM HSCs were enriched for biological processes related to the 
regulation of transcription, negative regulation of cell proliferation and antigen processing 
and presentation (Fig. 1D). 
Shortlisting candidate genes from differentially expressed gene list for functional screen 
To identify novel regulators of LT-HSC expansion, we selected genes annotated as “involved 
in transcription” (which include genes directly or indirectly involved in transcription) based 
on GO analysis, from the list of genes differentially expressed between murine FL E14.5 and 
ABM HSCs.[28] This yielded 269 differentially regulated genes, of which, 126 were more 
highly expressed in FL HSCs and 143 in ABM HSCs (Table S5).  Based on literature mining of 
this gene list, we identified 88 genes with known role in different aspects of hematopoiesis, 
such as self-renewal and differentiation of HSC, leukemia etc. (Fig. 2A and Table S6). 
Following removal of genes with known function in hematopoiesis, we identified a list of 
zebrafish orthologs for 123 of the genes differentially expressed between E14.5 FL and ABM 
HSCs (Fig. 2B and Table S7). We designed MOs against 18 of these genes, 9 of which were 
more highly expressed in E14.5 FL HSCs, and 9 in ABM HSCs (Fig. 2B and Table 1). To confirm 
the differential expression observed by RNA-seq, we performed qRT-PCR on 8 of the genes 
that were selected for functional validation, and demonstrated consistent 
increased/decreased gene expression in 3-5 separately isolated FL or ABM HSC populations 
(Fig. 2C). 
In vivo functional screen in Zebrafish identified novel genes with role in hematopoiesis  
The MOs were injected at different concentrations in 1-2 cell stage, double transgenic 
(Tg:gata1;DsRed/flk1;EGFP) zebrafish embryos wherein endothelial cells express EGFP under 
the flk1 promoter and erythrocytes express dsRed under the gata1 promoter. A similar 
approach was previously used by our group to identify hematopoietic regulators from a 
gene list created by comparing the global gene expression of primitive HSCs with 
hematopoietic progenitors from human umbilical cord blood and ABM.[29] 































































































































































































































































































































































































































 We assessed the presence and circulation of dsRed+ red blood cells and GFP+ endothelial 
cells at 48hpf by fluorescence microscopy. Five MOs (against tdg, uhrf1, uchl5, nfix, and 
ncoa1), caused a blood defect with either disruption in blood flow or reduction in 
gata1:Dsred expressing cells in more than 60% of embryos (Fig. 3A, and Table 1). In addition 
to blood defects, several other phenotypes, including defects in neural development, 
abnormalities in vasculature and remodeling of vessels in caudal vein plexus were also seen 
(Table S8). Injection of 4 MOs (against taf6l, zbtb20, tle2, and pura) caused early embryonic 
lethality even when low doses of MOs were injected (Table 1). Injection of the other 9 MOs 
did not cause any specific hematopoietic defects, while embryos developed normally. 
To evaluate the specificity of the MO knockdown, we used a 5-base pair (bp) mismatch 
control against uhrf1, tdg and uchl5 as well as a splice-blocking MO against tdg and uchl5. In 
embryos targeted with mismatch control MOs, we observed no difference in blood and 
endothelial formation relative to uninjected embryos at 48hpf (Fig. S2A). Knockdown of tdg 
with a splice-blocking MO caused a similar phenotype as observed following injection of the 
translation-blocking MO (Fig. S2B). By contrast, knockdown of uchl5 with a splice-blocking 
MO did not fully recapitulate the decrease in gata1+ cells or blood flow seen with the 
translation-blocking MO, even if the embryos were curled or bend from the trunk region 
(Fig. S2B).  
To further confirm the effect of the MOs against tdg, uhrf1, uchl5, and ncoa1 on 
hematopoiesis, we analyzed the expression levels of transcripts for lcp1 and hbae1 specific 
for erythroid and myeloid lineage, respectively, in the MO-treated 48hpf embryos by qRT-
PCR (Fig. 3B). These studies demonstrated that MO-based knockdown of tdg, uhrf1, and 
uchl5 resulted in a significant reduction of transcripts specific for erythroid and myeloid (Fig. 
3B). Knockdown of ncoa1 by contrast, caused no significant change in mature blood cell 
transcripts.  
Knockdown of tdg, uhrf1, and ncoa1 inhibit definitive hematopoiesis 
We next examined the expression of the definitive hematopoiesis markers runx1 and c-myb, 































































































































































































































































































































































































































 to assess the effect of the MOs on the emergence of definitive hematopoiesis. Lineage 
tracing of HSCs during early hematopoietic development demonstrated that expression of 
runx1 and c-myb appear in the AGM between 28-48 hrs [30,31]. We therefore analyzed the 
expression of c-myb and runx1 in tdg, uhrf1, uchl5 and ncoa1 morphants at 36hpf by whole-
mount in situ hybridisation (WISH). Based on transcript levels of c-myb and runx1 in 
different morphants, they were classified as normal, severely decreased and absent 
expression.  
In 80-90% of tdg, uhrf1 or ncoa1 morphant embryos, the c-myb signal was severely reduced 
or absent, with loss of c-myb signal in 50% of tdg and uhrf1 and 40% of ncoa1 morphant 
embryos (Fig. 4A-B). In addition, a severe reduction or absent runx1 signal was seen in ~80% 
of tdg, uhrf1 and ncoa1 morphants fish (Fig. 5A-B). However, we found fewer morphants 
fish with complete loss of runx1 signal compared with c-myb signal (Fig. 4A-B). In uchl5 
morphants, we only detected a severe loss of runx1 signal in 8% of the embryos (Fig. 4A-B). 
Likewise, reduction of the c-myb signal was less pronounced in uchl5 morphants, where no 
c-myb signal was detected in 20% of the embryos and a severely decreased signal in 30% of 
embryos (Fig. 4A-B). Noteworthy, when we carefully examined c-myb expression in the 
uchl5 morphant fish, we detected an accumulation of c-myb signal in the posterior blood 
island (PBI) region (Fig. 4A-B). Thus, these MO knockdown studies demonstrate a role of 
tdg, uhrf1 and ncoa1 in the development of definitive hematopoiesis in the AGM region of 



































































































































































































































































































































































































































 Discussion  
The function of LTR-HSCs in adult BM differs significantly from those in FL. During 
development, HSCs populate the FL at around E12.5, following which they expand 
extensively via symmetrical self-renewing cell divisions between E12.5 and 16.5, while form 
E16.5 onwards, FL HSCs migrate to the developing BM via the blood circulation. In the fetal 
BM, expansion of the HSCs continues albeit at a decreased rate, and LT-HSCs ABM loose the 
fetal HSC characteristics from 4-5 weeks after birth onwards. In the adult BM, LT-HSCs are 
largely quiescent and divide asymmetrically to generate short-term repopulating (STR) HSCs, 
which then repopulate the mature cell populations. As the molecular regulators for 
symmetrical stem cell divisions are yet to be identified, we compared the gene expression 
profile of LTR-HSCs derived from different FL stages and ABM. We used an RNA-Seq based 
approach that allows identification of unknown transcripts involved in the processes. As 
RNA-Seq provides absolute quantification of the levels of expression with significantly lower 
background noise, identification of subtle transcriptional differences can be captured.  
This was clearly the case in this study, as we did not only identify most of the known 
important hematopoietic regulators, but also several novel regulators. Studies to identify 
unknown transcripts, non-coding genetic elements as well as alternatively spliced 
transcripts, involved in the regulation of hematopoietic processes are ongoing. We also 
observed that differences in the transcriptome of HSCs isolated from FL tissues from 
different gestational stages were significantly less pronounced, compared with differences 
observed between the expressed transcriptome of FL and ABM HSCs (data not shown). 
Further analysis of these subtle differences between the different stages of FL HSC 
development might identify additional regulators involved in hematopoietic development or 
HSC function within the FL tissue.  
In this study, we focused on differential gene expression between FL14.5 and BM HSCs, 
stages where HSCs are actively proliferating and remain quiescent, respectively. Two recent 
studies have used microarray based gene expression analysis to compare the transcriptome 































































































































































































































































































































































































































 of LT-HSCs in FL E14.5 and ABM [6,32]. McKinny-Freeman et al, who isolated FL HSCs as Lin-
Sca-1+c-kit+CD150+CD48- cells and ABM HSCs as Lin-Sca-1+c-kit+CD150+CD34- cells, identified 
128 differentially expressed genes between FL E14.5 and BM HSC (threshold; log2FC ≥2, FDR 
≤ 0.05)[6]. Among these, 128 differentially expressed genes, 83 genes (~60%) were also 
found in our list of 576 differentially regulated genes (Fig. S3). In a second study, Beerman 
et al., who isolated FL HSCs Lin-Sca-1+c-kit+CD150+CD48- cells and ABM HSCs as Lin-Sca-1+c-
kit+CD34-Flk2-Il7ra- cells, identified 403 genes differentially expressed between FL and ABM 
HSCs, among which 147 genes (~35%) were also identified in our dataset (Fig. S3A and 
S3B,C) [32]. Whether the differences in markers used for HSC isolation might explain the 
decreased overlap between genes found differentially expressed in our study and the 
Beerman et al., study is not clear. Nevertheless, significant concordance exists between the 
three studies. 
In this study we focused on the role of transcription regulators, i.e. genes that are directly or 
indirectly involved in transcription, as these may be major players in the different 
proliferative behavior of FL and ABM HSCs. Following removal of genes with known function 
in hematopoiesis, and defining for which transcripts a putative zebrafish orthologue exists, 
we shortlisted 123 differentially expressed E14.5 FL and ABM HSCs. For 18 genes from this 
list, MOs were designed to assess the effect on the emergence of HSCs in double transgenic 
(Tg:gata1;DsRed/flk1;EGFP) Danio rero embryos.  Injection of 9 of these MOs caused defects 
in zebrafish larvae.   
Embryonic lethality was observed following injection of MOs against taf6l, Zbtb20, tle2, and 
pura. Whether they would affect HSC emergence can thus not be defined using this 
approach. Currently no taf6l and tle2 knockout mice have been described. However, in X. 
tropicalis, the Groucho/TLE family member, Tle2, together with FoxG1 is involved in 
specification of the ventral telencephalon.[33] Loss of Zbtb20 in mouse results in severe 
growth retardation, aberrant glucose metabolism and post-natal lethality.[34] Zbtb20 acts 
as a transcriptional repressor of alpha-fetoprotein (AFP) and is involved in specification of 
the CA1 field in developing hippocampus.[35,36] Finally, loss of Pura in mouse leads to 































































































































































































































































































































































































































 death post-natally between d18-28 days, and the mice show significantly decreased 
numbers of neurons in the hippocampus and cerebellum, indicating its role in brain 
development.[37] 
We also demonstrated that MOs against tdg, uchl5, ncoa1, nfix and uchl5 affected the gata-
1+ cell number or circulation at 48hpf. For most MOs, we also identified abnormalities in 
neural development and vasculature. Combined defects in HSC emergence and vasculature 
might be due to the fact that hematopoietic and vascular cells originate from a common 
progenitor, i.e. the hemogenic endothelium. The effects of MOs targeting tdg and nfix on 
brain development are consistent with the known roles of these transcriptional regulators 
in brain development.[38,39]  
Aside from assessing the effects of the MOs against tdg, uchl5, ncoa1, and uchl5 on gata-1+ 
cells in the zebrafish circulation, we also assessed the emergence of runx1+ and c-myb+ HSCs 
by WISH on 36hpf, at which time the definitive HSCs emerge in the AGM. These studies 
revealed that MOs against tdg, uchl5, ncoa1, and to a lesser extent uchl5, resulted in a 
significantly lower numbers of HSCs appearing in the ICM. Among these genes, tdg, uchl5 
and uhrf1 are more highly expressed in FL HSCs while ncoa1 is more highly expressed in 
ABM HSCs. 
Although myeloid and erythroid specific gene expression as well as the number of gata-1+ 
cells were significantly decreased in uchl5 morphants, we did not observe significant 
changes in HSC numbers in the AGM. However, we found an accumulation of c-myb+ 
hematopoietic precursors in the PBI, which represents a region where bipotent 
erythromyeloid progenitors (EMP) reside temporarily, between 24-36 hpf and marks a 
transient definitive wave of hematopoiesis which exists between primitive and definitive 
hematopoiesis.[40] This suggests that uchl5 may be important for the differentiation of 
EMPs, causing their accumulation with concomitant loss of mature blood cells. UCHL5 is a 
deubiquitinating enzyme, which can reverse Smurf-mediated ubiquitination of Smad 
transcription factors,[41] known to play important roles in hematopoietic development, as 































































































































































































































































































































































































































 well as in postnatal HSCs. Uchl5 knockout mice die prenatally, because of severe defects in 
brain development[42]. 
The ncoa1 morphants were the only ones wherein mature blood cell marker expression was 
not affected, even if HSCs in the AGM were decreased. Ncoa1 is known to play a role in 
chromatin remodeling through the recruitment of other coactivators. Ncoa1 knockout mice 
show a partial resistance to sex steroid hormones, affecting the reproductive system, the 
skeleton, glucose production [43] and has a role in the development of Purkinje cells in the 
brain, resulting in moderate motor dysfunction [44]. Why loss of ncoa1 expression 
decreases the number of c-myb/runx1+ HSCs in the AGM of zebrafish larvae, even though it 
is more highly expressed in the ABM, will need to be further investigated. 
Knockdown of tdg and uhrf1 had profound effects on the development of the 
hematopoietic system at 48hpf (as demonstrated by lack of circulating blood, and severely 
decreased expression of runx1 and c-myb mRNA). TDG and UHRF1 play important roles in 
DNA methylation, as well as in DNA repair. Tdg is one of the enzymes that starts base 
excision repair (BER), which corrects among others damage to the DNA by oxidation; while 
Uhrf1 plays a role in DSBR [45-47]. We recently reported significantly higher expression in 
the expression of OxPhos genes in FL compared with BM HSCs, which was accompanied 
with presence of significantly more and more active mitochondria, increased oxygen 
consumption rate and increased ROS levels in FL HSCs compared with BM HSCs [23]. KEGG 
pathway analysis also demonstrated that all DNA repair pathways were significantly more 
enriched in FL compared to BM HSCs. We speculate that this may be required for FL HSCs to 
be capable to deal with the significantly higher ROS levels, known to cause DNA damage, 
and HSC exhaustion. In line with this hypothesis, we found that MO knockdown of two 
genes involved in DNA repair, namely Tdg and Uhrf1 caused significant hematopoietic 
toxicity in the zebrafish model. Knockout of Tdg and Uhrf1 in mice is associated with 
embryonic lethality [48] / early gestational death [49]; therefore their effect on mammalian 
hematopoiesis remains unevaluated. Lineage specific knockout studies or shRNA mediated 
inhibition of both genes in HSCs will be required to address if Tdg and Uhrf1 affect HSC in 
































































































































































































































































































































































































































In conclusion, we identified 3 new hematopoietic regulators that affect the emergence 
and/or proliferation of definitive HSCs in zebrafish. It will obviously be of interest to 
demonstrate in future studies that knockdown or overexpression of these regulators in 
mammalian HSCs can increase HSC expansion.  
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 Figure Legends: 
 
 
Figure 1. Genome-scale transcriptional profiling between murine FL and ABM LT-HSC. 
A. RNASeq analysis was performed as described in an earlier publication [23]. Principle 
component analysis across different cell populations.  
B. Number of differentially regulated genes obtained after pair-wise comparison between LT-
HSCs from murine FL E14.5 and adult BM. Threshold used is: Log2FC ≥ 1 FDR ≤ 0.05. 
C-D. Gene set enrichment analysis for GO biological process for genes differentially expressed 
between murine FL E14.5 and ABM HSCs using the web-based application Genecodis3. 

































































































































































































































































































































































































































Figure 2. Shortlisting of genes differentially regulated between murine E14.5 FL and ABM. 































































































































































































































































































































































































































 A. Heat map of shortlisted differentially expressed genes selected on basis of the GO annotation 
(Biological process: transcription) and with known role in HSC function.  
B. Heat map of shortlisted differentially expressed gene selected on basis of the GO annotation 
(Biological process: transcription) and having zebrafish ortholog with no known role in 
regulation of HSC function between FL14.5 and ABM LT-HSC. 




































































































































































































































































































































































































































































































































































































































































































































































































































































 Figure 3. Morpholino knockdown of target genes in Tg:gata1;DsRed/flk1;EGFP zebrafish. 
A. Representative fluorescence images of embryos (48 hpf): (a-b) uninjected control; and after 
injection of MOs against uhrf1 (d-f), tdg (g-i), uchl5 (j-i), and ncoa1(m-o). 
B. Gene expression of lcp1 (myeloid specific) and hbae1 (erythroid specific) in MO injected 
embryos relative to uninjected controls at 48hpf. (n= 4-6 (1replicate=3 x 6 embryos), t test, * 
p-value ≤ 0.05). 
 
  
































































































































































































































































































































































































































































































































































































































































































































































































































































 Figure 4. Expression of c-myb in control and morpholino targeted embryos by WISH. 
A. Representative in situ image of c-myb expression in uninjected control embryos and embryos 
injected with MOs against uhrf1, tdg, ncoa1, and uchl5. 
B. Quantification of embryos with different degrees of c-myb expression following injection with 
MOs against uhrf1, tdg, ncoa1, and uchl5. 
 
  
































































































































































































































































































































































































































































































































































































































































































































































































































































 Figure 5. Expression of runx1 in control and morpholino targeted embryos by WISH. 
A. Representative in situ image of runx1 expression in uninjected control embryos and embryos 
injected with MOs against uhrf1, tdg, ncoa1, and uchl5. 
B. Quantification of embryos with different degrees of runx1 expression following injection with 
MOs against uhrf1, tdg, ncoa1, and uchl5. 
 
  
































































































































































































































































































































































































































Table1. Morpholino knockdown of shortlisted candidate genes. 
  
Gene Symbol MO translational/splice  Dose Hematopoietic Phenotype Expression  
Uchl5 ATG / Splice morpholino 4 ng  ~60% of embryos showed blood defect  FL14.5  
Uhrf1 ATG morpholino 3 ng  ~60-70% of embryos showed blood defect  FL14.5  
Tdg ATG / Splice morpholino 6 ng  ~70% of embryos showed blood defect  FL14.5  
Taf6l ATG morpholino 1.5 ng Embryonic Lethal  FL14.5  
Thap7 ATG morpholino 6 ng  No blood defect FL14.5  
Timeless ATG morpholino 6 ng  No blood defect FL14.5  
Trip13 ATG morpholino 6 ng  No blood defect FL14.5  
Depdc1a ATG morpholino 6 ng  No blood defect FL14.5  
Tada2a ATG morpholino 6 ng  No blood defect FL14.5  
Nfix ATG morpholino 3ng ~60% of embryos showed blood defect  BM 
Ncoa1 ATG morpholino 4.5 ng ~70% embryo showed blood defec BM 
Zbtb20 ATG morpholino 2 ng Embryonic Lethal  BM 
Tle2 ATG morpholino 1.5 ng Embryonic Lethal  BM 
Pura ATG morpholino 1.5 ng Embryonic Lethal  BM 
Lpin1 ATG morpholino 6 ng  No blood defect BM 
Tsc22d3 ATG morpholino 6 ng  No blood defect BM 
Irf6 ATG morpholino 6 ng  No blood defect BM 
Bhlhe40 ATG morpholino 6 ng  No blood defect BM 































































































































































































































































































































































































































 Supplementary figure legends:  
Figure. S1: Mapping statistics and correlation analysis after RNA-Seq for LT-HSC from murine FLs 
and BM: A) Percentages of reads mapped to reference genome after RNA-seq analysis performed 
on murine FL E14.5 and adults BM LT-HSCs. B) A percentage of reads mapped to genes after RNA-
seq analysis performed on FL E14.5 and adults BM LT-HSCs. C) The correlation coefficients 
between replicates of different samples derived from FL E14.5 and adults BM LT-HSCs. 
 
Figure. S2: Morpholino knockdown of target genes in Tg:gata1;DsRed/flk1;EGFP zebrafish line: 
A) Representative fluorescence images of embryos (48 hpf): (a-c) uninjected control; after 
injection of 5-base pair (bp) mismatch control MOs against uhrf1 (d-f), tdg (g-i) and uchl5 (j-l). B) 
Representative fluorescence images of embryos (48 hpf): (a-c) uninjected control; after injection 
of splice-blocking MOs against tdg (d-f) and uchl5 (g-i). 
 
Figure. S3: Cross-comparison of RNA-seq with published microarray dataset: 
A. Comparison of differentially expressed genes in this study with results from McKinny-Freeman 
et al., and Beerman et al., [6,32].  Venn diagram depicting the overlap of differentially regulated 
genes in these three independent studies. Threshold used is: Log2FC ≥2, FDR ≤0.05. B) 
Comparison of differentially expressed genes in this study with results from McKinny-Freeman et 
al., and Beerman et al., [6,32].  Depicted is the number of genes differentially expressed between 
FL E14.5 and BM in the three independent studies and overlap estimated after cross-comparison 































































































































































































































































































































































































































 of differential gene expression. C) Description of cell surface markers used for purification of LT-
HSC from E14.5 FL and adult bone marrow in McKinny-Freeman et al., and Beerman et al., [6,32]. 
  

































































































































































































































































































































































































































Mapping statistics and correlation analysis after RNA-Seq for LT-HSC from murine FLs and 
BM 
  
































































































































































































































































































































































































































































































































































































































































































































































































































































 Morpholino knockdown of target genes in Tg:gata1;DsRed/flk1;EGFP zebrafish line 
  

































































































































































































































































































































































































































Cross-comparison of RNA-seq with published microarray dataset 
  
































































































































































































































































































































































































































table s1. qrt-pcr primer sequences.xlsx 
  
































































































































































































































































































































































































































table s2. morpholino list.xlsx 
  
































































































































































































































































































































































































































table s3. all gene coverage and rpkm.xlsx 
  
































































































































































































































































































































































































































table s4. pair-wise comparion hsc from e14.5 and bm.xlsx 
  
































































































































































































































































































































































































































table s5. go biological process trancription.xlsx 
  
































































































































































































































































































































































































































table s6. gene with known role in hsc self-renewal or hematopoiesis.xlsx 
  
































































































































































































































































































































































































































table s7. genes with unknown role in hematopoiesis with zebrafish orthologs.xlsx 
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